Use of EGFR transactivation inhibitors in human cancer

• 收藏
• 分享

专利权人:

Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.

发明人:

Ullrich, Axel,Gschwind, Andreas,Fischer, Oliver,Leserer, Michael,Schafer, Beatrix

申请号：

AU2008249216

公开号：

AU2008249216B2

申请日:

2008.11.26

申请国别(地区):

AU

年份:

2012

代理人:

摘要：

#$%^&*AU2008249216B220120119.pdf#####P OPER HPM Ma.Planck-Gesclischaf30691605 Div p.c doc-24/11/2008 ABSTRACT 5 The present invention relates to the use of a compound which is capable of inhibiting activation of a growth factor receptor of the EGFR-family for the prevention or treatment of processes associated with increased G-protein mediated signal transduction.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/